JUNS Surges on Exclusive U.S. Rights Deal for ALA-002 and New Patents: PharmAla Biotech Sets Strategic Foundation
Market Chameleon (Fri, 21-Aug 10:28 AM)
JUNS Secures Exclusive U.S. License to ALA-002 as PharmAla Biotech Expands Patent Estate and Strategic Partnerships
Market Chameleon (Fri, 21-Aug 7:28 AM)
